Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Recidiva di infarto miocardico acuto dopo MINOCA: risultati di un registro multicentrico nazionale
Anno:
2023
Razionale.La gestione dei pazienti con infarto miocardio acuto con arterie coronarie non ostruite (MINOCA) rappresenta spesso una sfida per il cardiologo. La prognosi di questi pazienti non sempre è benigna, infatti alcuni di essi possono andare incontro a re-infarto, sebbene vi siano dati limitati sulle caratteristiche di tali pazienti.Lo…
PREDITTORI ELETTROCARDIOGRAFICI DI FIBRILLAZIONE VENTRICOLARE PRIMARIA DURANTE UN PRIMO INFARTO MIOCARDICO ACUTO
Anno:
2023
Introduzione: Pochi studi di esigua numerosità campionaria hanno valutato i predittori elettrocardiografici (ECG) di  fibrillazione ventricolare (FV) prima della riperfusione durante un primo infarto miocardico acuto (IMA). Nessuno ha tenuto conto del tempo intercorso tra insorgenza dei sintomi ed ECG.   Obiettivi: valutare i predittori  ECG di FV primaria…
Determinanti genetici e non della variabilità clinica in un caso familiare di cardiomiopatia ipertrofica con mutazione patogena eterozigote MYPBC3
Anno:
2023
Tra le principali cause di cardiomiopatia ipertrofica (HCM) ci sono le mutazioni nel gene MYBPC3,che codifica per la proteina C legante la miosina C (cMyBP-C).Le mutazioni troncanti sono riconosciute come causative in molti pazienti HCM e recentemente,anche quelle missenso sembrano essere clinicamente correlate alla malattia, come la mutazione E258K.Questa…
Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis
Anno:
2023
Background: This study aims to evaluate the prevalence and clinical significance of the right ventricular pulmonary arterial (RV-PA) uncoupling in patients with cardiac amyloidosis (CA). Methods: The study population consisted in 92 consecutive patients with CA (age 71.1±12.2 years, 71% males; 47% with immunoglobulin light chain (AL), 53% with…
Dapagliflozin increases pAMPK and reduces myocardial and renal NF-kB expression in preclinical models of short-term doxorubicin cardiotoxicity through MYD-188 and NLRP3 pathways
Anno:
2023
Background: Doxorubicin-mediated adverse cardiovascular events are among the leading causes of morbidity and mortality in breast cancer patients. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have recently been shown to be of therapeutic value in patients with type 2 diabetes, chronic kidney disease, and heart failure with reduced ejection fraction (HFrEF),…
TOTALLY ENDOSCOPIC VALVE SURGERY: FEASIBILITY AND ADVANTAGES IN OBESE PATIENTS
Anno:
2023
OBJECTIVE Obesity is a relative contraindication to Minimally Invasive Cardiac Surgery because of its technical challenges. Aim of the study is to evaluate if totally endoscopic approach is feasible in treating heart valve’s pathology in obese patients and if 30-days outcomes and complications are non-inferior to non-obese patients. METHODS…
Intravascular lithotripsy for the treatment of severely calcified coronary stenosis in Acute Myocardial Infarction
Anno:
2023
Background Little is known about intraprocedural and mid-term results of intravascular lithotripsy (IVL) use in patients with acute MI. Methods In Our retrospective analysis, data from 21 Centers in Italy and Spain between January 2020 and November 2021 were collected. Patients were allocated to the AMI-group when IVL was…
THE ROLE OF PREPARTICIPATION SCREENING IN DETECTING SILENT CORONARY ARTERY DISEASE IN MASTER ATHLETES: A WAY TO PREVENT EXERCISE-RELATED ADVERSE CARDIOVASCULAR EVENTS
Anno:
2023
Regular exercise reduces morbidity and mortality from cardiovascular diseases through cardiac and systemic adaptations including the increased coronary blood flow, an improved endothelial function, a slower progression of atherosclerotic processes as well as the stabilization of pre-existing lesions. However, long-term exercise is frequently associated with adverse cardiovascular events in…
COVID-19 DIAGNOSIS AND MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ADMITTED IN ITALY DURING THE NATIONAL OUTBREAK
Anno:
2023
Background and objective: There are limited data on the clinical impact of Covid-19 in patients with acute myocardial infarction (AMI). Aim of this work is to assess the impact of Covid-19 infection on mortality in AMI patients admitted during the national outbreak in Italy. Methods: Retrospective nationwide cohort study…
Prognostic Impact of Percutaneous Coronary Intervention in Chronic Dialysis Patients with Acute Myocardial Infarction: Findings From the Lombardy Health Database.
Anno:
2023
Background. Patients on chronic dialysis are less likely to receive percutaneous coronary intervention (PCI) for treatment of acute myocardial infarction (AMI). This is due to the lack of evidence from randomized trials, concerns about possible PCI-related side effects, and multimorbidity. Thus, routine use of PCI for treatment of dialysis…